kabutan

ASKA Pharmaceutical Holdings Co.,Ltd.(4886) Summary

4886
TSE Prime
ASKA Pharmaceutical Holdings Co.,Ltd.
2,298
JPY
+192
(+9.12%)
Jan 29, 3:30 pm JST
15.02
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
2,285.9
Jan 29, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
13.0
PBR
0.98
Yield
2.39%
Margin Trading Ratio
14.39
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
2,099 JPY 13.70 USD
Previous Close Jan 28
2,106 JPY 13.79 USD
High Jan 29, 2:08 pm
2,417 JPY 15.80 USD
Low Jan 29, 9:06 am
2,071 JPY 13.52 USD
Volume
786,200
Trading Value
1.81B JPY 0.01B USD
VWAP
2306.93 JPY 15.08 USD
Minimum Trading Value
229,800 JPY 1,502 USD
Market Cap
0.07T JPY 0.43B USD
Number of Trades
3,529
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
267
1-Year High Jan 29, 2026
3,529
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 27,300 196,500 7.20
Jan 16, 2026 20,500 114,200 5.57
Jan 9, 2026 15,900 120,200 7.56
Dec 26, 2025 15,900 123,000 7.74
Dec 19, 2025 15,100 114,000 7.55
Company Profile
ASKA Pharmaceutical Holdings Co., Ltd. specializes in gynecology and urology, with hormone preparations as its main products. The company sells generic drugs for Takeda and also develops new drugs.
Sector
Pharmaceuticals
ASKA Pharmaceutical Holdings Co., Ltd. focuses on the pharmaceutical business as its core, while also operating in animal health and clinical testing sectors. In the pharmaceutical business, "Aska Pharmaceutical" specializes in products for internal medicine, obstetrics and gynecology, and urology, which are distributed through Takeda Pharmaceutical Company. The animal health business is managed by "Aska Animal Health," which procures some products from Aska Pharmaceutical while also outsourcing manufacturing to Aska Pharmaceutical. The clinical testing business is operated by "Aska Pharmaceutical Medical," which leases facilities from Aska Pharmaceutical for its operations. Additionally, Aska Pharmaceutical handles the procurement and sales of medical devices and health foods. The company has adopted a holding company structure to manage its group companies effectively.